C12N 2502/1164
Nk cells
Official title: NK cells
C12N2502/1164 (Nk cells) appears on 11 US grants and 42 published applications in this corpus.
Search patents in C12N- Granted patents
- 11
- Published applications
- 42
- Assignees
- 38
- Inventors
- 106
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 3 |
| 2019 | 0 | 4 |
| 2020 | 0 | 4 |
| 2021 | 1 | 1 |
| 2022 | 0 | 7 |
| 2023 | 4 | 8 |
| 2024 | 1 | 4 |
| 2025 | 2 | 3 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for treating an immune disorder-related disease by reducing autoreactivity in a T cell compartment9 Jun 2026US 12,649,905 B2Hackensack University Medical Center
- Expansion of natural killer and chimeric antigen receptor-modified cells28 Oct 2025US 12,453,773 B2Houston Methodist Hospital
- Methods of treating cancer using NK cells4 Mar 2025US 12,239,665 B2Honed Life Sciences, LLC
- Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto3 Dec 2024US 12,156,893 B2The Regents of the University of California
- In vitro immune synapse system and method of in vitro evaluating immune response using the same5 Dec 2023US 11,834,647 B2National Pingtung University of Science and Technology
- Cancer models1 Oct 2026US 2026/0297534 A1Carcinotech Ltd
- Microfluidic System for Transplantation of Mitochondria in Immune Effector Cells6 Aug 2026US 2026/0224623 A1Northeastern University
- Compositions and methods for treating cancer2 Jul 2026US 2026/0183328 A1Celularity Inc.
- Purifying tcr-modified t cells using tcr-specific car-nk cells14 May 2026US 2026/0130994 A1Charite-Universitatsmedizin Berlin
- Compositions and methods for enhancing immune tolerance5 Jun 2025US 2025/0177453 A1President and Fellows of Harvard College
Most cited
By later US patents
- Formulation and method for preparing specific T cell, and method for preparing the formulation2US 9,597,383 B2Fullhope Biomedical Co., Ltd. · 2017
- Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto1US 11,617,771 B2The Regents of the University of California · 2023